| abstract |
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to immunotherapy of cancer. The present invention also relates to tumor-transfer to a patient, either alone or in combination with other tumor-associated peptides, which may serve, for example, as active pharmaceutical ingredients of vaccine compositions to promote an anti-tumor immune response or to promote cells ex vivo. Associated T cell epitopes. A peptide bound to a molecule of the major histocompatibility complex (MHC), or the peptide itself, may be the target of antibodies, soluble T cell receptors and other binding molecules. |